Illumina teams up on biomarker services; Big Pharma group backs trial collaboration platform;

> Big Pharma consortium TransCelerate BioPharma picked Cognizant ($CTSH) to develop a clinical trial collaboration platform. News

> Illumina ($ILMN) teamed up with Cypher Genomics to provide biomarker discovery services. Item

> Genomics England began recruiting software engineers and bioinformaticians. Post

> Oxford Gene Technology received a grant to develop NGS analysis software. Release

> PHT Corporation reported surging demand for its electronic clinical outcome assessment system. Item

> Simulations Plus agreed to buy clinical trial data analysis firm Cognigen for $7 million. Release

> All 14 of the Broad Institute's HiSeq Xs are now running and have so far sequenced 650 genomes. Post

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.